Affinity labels as tools for the identification of opioid receptor recognition sites

Farmaco

Volumn 56, Issue 3, 2001, Pages 191-196

  Portoghese, Philip S ^a   El Kouhen, Rachid ^b   Law, Ping Y ^b   Loh, Horace H ^b   Le Bourdonnec, Bertrand ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; BETA FUNALTREXAMINE; CHLORNALTREXAMINE; CYSTEINE; DIMER; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ISOINDOLE DERIVATIVE; LIGAND; LYSINE; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; NALTREXONE; PHTHALALDEHYDE;

AFFINITY LABELING; ARTICLE; BINDING AFFINITY; CHO CELL; COVALENT BOND; CROSS LINKING; DRUG ANTAGONISM; DRUG BINDING SITE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; NONHUMAN; PHARMACOPHORE; REACTION ANALYSIS;

AFFINITY LABELS; BINDING SITES; HUMANS; RECEPTORS, OPIOID;

EID: 0035304607     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(01)01040-0     Document Type: Article

References (23)

1. Takemori A.E., Portoghese P.S. Affinity labels for opioid receptors. Annu. Rev. Pharmacol. 25:1985;193-223.
2. Chen C., Yin J., De Riel J.K., Desjarlais R., Raveglia L.F., Zhu J., Liu-Chen L.-Y. Determination of the amino acid residue involved in [3H]β-funaltrexamine covalent binding in the cloned rat μ opioid receptor. J. Biol. Chem. 271:1996;21422-21429.
3. Zhu J., Yin J., Law P.-Y., Claude P.A., Rice K.C., Evans C.J., Chen C., Yu L., Liu-Chen L.-Y. Irreversible binding of cis-(+)-3-methylfentanyl isothiocyanate to the δ opioid receptor and determination of its binding domain. J. Biol. Chem. 271:1996;1430-1434.
4. Zeng F.-Y., Wess J. Identification and molecular characterization of m3 muscarinic receptor dimers. J. Biol. Chem. 274:1999;19487-19497.
5. Gkoutos G.V., Higgs C., Bywater R.P., Gouldson P.R., Reynolds C.A. Evidence for dimerization in the β2-adrenergic receptor from the evolutionary trace method. Int. J. Quantum Chem. 74:1999;371-379.
6. Gouldson P.R., Snell C., Bywater R.P., Higgs C., Reynolds C.A. Domain swapping in G-protein coupled receptor dimers. Protein Eng. 11:1998;1181-1193.
7. Maggio R., Barbier P., Colelli A., Salvadori F., Demontis G., Corsini G.U. G protein-linked receptors: pharmacological evidence for heterodimers. J. Pharmacol. Exp. Ther. 291:1999;251-257.
8. Cvejic S., Devi L.A. Dimerization of the delta opioid receptor; implication for a function in receptor internalization. J. Biol. Chem. 272:1997;26959-26964.
9. Jordan B.A., Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature. 399:1999;697-700.
10. Sayre L.M., Larson D.L., Takemori A.E., Portoghese P.S. Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid antagonist activities. Evidence for the existence of different μ receptor subtypes in different tissues. J. Med. Chem. 27:1984;1325-1335.
11. Portoghese P.S., Larson D.L., Jiang J.B., Caruso T.P., Takemori A.E. Synthesis and pharmacological characterization of an alkylating analogue (chlornaltrexamine) of naltrexone with ultralong-lasting narcotic antagonist properties. J. Med. Chem. 22:1979;168-173.
12. Caruso T.P., Takemori A.E., Larson D.L., Portoghese P.S. Chloroxymorphamine, an opioid receptor site-directed alkylating agent having narcotic agonist activity. Science. 204:1979;316-318.
13. Kenakin T. The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol. Rev. 48:1996;413-463.
14. Portoghese P.S., Takemori A.E. Different receptor sites mediate opioid agonism and antagonism. J. Med. Chem. 26:1983;1341-1343.
15. Portoghese P.S. Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists. Trends Pharmacol. Sci. 10:1989;230-235.
16. Lee K.S., Drescher D.G. Fluorometric amino acid analysis with o-phthalaldehyde (OPA). Int. J. Biochem. 9:1978;457-467.
17. Wong O.S., Sternson L.A., Schowen R.L. Reaction of o-phthalaldehyde with alanine and thiols: kinetics and mechanism. J. Am. Chem. Soc. 107:1985;6421-6422.
18. (a) A. Pandey, S. Sheikh, S.S. Katiyar, Identification of cysteine and lysine residues present at the active site of beef liver glutamate dehydrogenase by o-phthalaldehyde, Biochim. Biophys. Acta 1293 (1996) 122-128.
19. (b) W.S. Blaner, J. Churchich, Succinic semialdehyde dehydrogenase, J. Biol. Chem. 254 (1979) 1794-1798.
20. (c) R.N. Puri, D. Bhatnagar, J.R. Roskoski, Inactivation of yeast hexokinase by o-phthalaldehyde: evidence for the presence of a cysteine and a lysine at or near the active site, Biochim. Biophys. Acta 957 (1988) 34-46.
21. (d) P.P. Giovannini, M. Rippa, F. Dallocchio, M. Tetaud, M.P. Barrett, S. Hanau, The cross-linking by o-phthalaldehyde of two amino acid residues at the active site of 6-phosphogluconate dehydrogenase, Biochem. Mol. Biol. Int. 43 (1997) 153-160.
22. (e) G. Matteucci, V. Lanzara, C. Ferrari, S. Hanau, C.M. Bergamini, Active site of erythrocyte transglutaminase by o-phthalaldehyde, Biol. Chem. 379 (1998) 921-924.
23. http://www.opioid.umn.edu.